Structurally modulated codelivery of siRNA and Argonaute 2 for enhanced RNA interference
Small interfering RNA (siRNA) represents a promising class of inhibitors in both fundamental research and the clinic. Numerous delivery vehicles have been developed to facilitate siRNA delivery. Nevertheless, achieving highly potent RNA interference (RNAi) toward clinical translation requires effici...
| Główni autorzy: | , , , , , , |
|---|---|
| Kolejni autorzy: | |
| Format: | Artykuł |
| Wydane: |
National Academy of Sciences (U.S.)
2018
|
| Dostęp online: | http://hdl.handle.net/1721.1/119482 https://orcid.org/0000-0002-4031-7286 https://orcid.org/0000-0002-7639-2122 https://orcid.org/0000-0001-9695-3604 |
| Streszczenie: | Small interfering RNA (siRNA) represents a promising class of inhibitors in both fundamental research and the clinic. Numerous delivery vehicles have been developed to facilitate siRNA delivery. Nevertheless, achieving highly potent RNA interference (RNAi) toward clinical translation requires efficient formation of RNAinduced gene-silencing complex (RISC) in the cytoplasm. Here we coencapsulate siRNA and the central RNAi effector protein Argonaute 2 (Ago2) via different delivery carriers as a platform to augment RNAi. The physical clustering between siRNA and Ago2 is found to be indispensable for enhanced RNAi. Moreover, by utilizing polyamines bearing the same backbone but distinct cationic side-group arrangements of ethylene diamine repeats as the delivery vehicles, we find that the molecular structure of these polyamines modulates the degree of siRNA/Ago2-mediated improvement of RNAi. We apply this strategy to silence the oncogene STAT3 and significantly prolong survival in mice challenged with melanoma. Our findings suggest a paradigm for RNAi via the synergistic coassembly of RNA with helper proteins. Keys: siRNA; RNA interference; Argonaute; polyamines; gene delivery |
|---|